Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2016 Nov 7;11(11):1935-1943.
doi: 10.2215/CJN.00280116. Epub 2016 Sep 15.

Development of a Multicenter Ward-Based AKI Prediction Model

Affiliations
Multicenter Study

Development of a Multicenter Ward-Based AKI Prediction Model

Jay L Koyner et al. Clin J Am Soc Nephrol. .

Abstract

Background and objectives: Identification of patients at risk for AKI on the general wards before increases in serum creatinine would enable preemptive evaluation and intervention to minimize risk and AKI severity. We developed an AKI risk prediction algorithm using electronic health record data on ward patients (Electronic Signal to Prevent AKI).

Design, setting, participants, & measurements: All hospitalized ward patients from November of 2008 to January of 2013 who had serum creatinine measured in five hospitals were included. Patients with an initial ward serum creatinine >3.0 mg/dl or who developed AKI before ward admission were excluded. Using a discrete time survival model, demographics, vital signs, and routine laboratory data were used to predict the development of serum creatinine-based Kidney Disease Improving Global Outcomes AKI. The final model, which contained all variables, was derived in 60% of the cohort and prospectively validated in the remaining 40%. Areas under the receiver operating characteristic curves were calculated for the prediction of AKI within 24 hours for each unique observation for all patients across their inpatient admission. We performed time to AKI analyses for specific predicted probability cutoffs from the developed score.

Results: Among 202,961 patients, 17,541 (8.6%) developed AKI, with 1242 (0.6%) progressing to stage 3. The areas under the receiver operating characteristic curve of the final model in the validation cohort were 0.74 (95% confidence interval, 0.74 to 0.74) for stage 1 and 0.83 (95% confidence interval, 0.83 to 0.84) for stage 3. Patients who reached a cutoff of ≥0.010 did so a median of 42 (interquartile range, 14-107) hours before developing stage 1 AKI. This same cutoff provided sensitivity and specificity of 82% and 65%, respectively, for stage 3 and was reached a median of 35 (interquartile range, 14-97) hours before AKI.

Conclusions: Readily available electronic health record data can be used to improve AKI risk stratification with good to excellent accuracy. Real time use of Electronic Signal to Prevent AKI would allow early interventions before changes in serum creatinine and may improve costs and outcomes.

Keywords: Acute Kidney Injury; Algorithms; Area Under Curve; Demography; Early Intervention (Education); Electronic Health Records; Humans; Inpatients; Patients’ Rooms; Probability; ROC Curve; Risk; Sensitivity and Specificity; acute kidney injury; acute renal failure; biomarker; clinical nephrology; creatinine; electronic health records; hospitalization; risk assessment; vitals signs.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Flow diagram demonstrating the size of the original cohort, rationale for those subjects who were excluded and the size of the final cohort.
Figure 2.
Figure 2.
Importance of variables in the final model scaled to a maximum of 100. The figure shows the importance of each variable in the final model. The variables are weighted according to their chi-squared value in the final model. Serum creatinine (Cr) had the highest chi–squared value and therefore, was assigned a value of 100. On the basis of this assignment, all of the remaining variables were scaled according to their respective chi–squared values. As shown, BUN and heart rate (HR) were the second and third most heavily weighted variables in the model. Alk Phos, alkaline phosphatase; AST, aspartate transaminase; AVPU, alert, voice, pain, unresponsive (mental status measure); Bicarb, serum bicarbonate; DBP, diastolic BP; Hb, hemoglobin; ICU, intensive care unit; O2sat, oxygen saturation; PPI, pulse pressure; RR, respiratory rate; SBP, systolic BP; Temp, temperature; WBC, white blood cell count.
Figure 3.
Figure 3.
Cumulative percentage of patients reaching a cutoff of ≥0.01 in the 72 hours before stage 1 AKI. The plot shows the cumulative percentage of patients who reached a cutoff of ≥0.01 before developing stage 1 AKI (solid line). The dashed line represents the cumulative percentage of those patients reaching the same threshold without AKI over the course of the first 72 hours of admission. Data from within 1 hour of AKI were omitted from the original graph, and thus, time zero results are not included.

References

    1. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW: Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 16: 3365–3370, 2005 - PubMed
    1. Hobson C, Ozrazgat-Baslanti T, Kuxhausen A, Thottakkara P, Efron PA, Moore FA, Moldawer LL, Segal MS, Bihorac A: Cost and mortality associated with postoperative acute kidney injury. Ann Surg 261: 1207–1214, 2015 - PMC - PubMed
    1. Koyner JL, Cerdá J, Goldstein SL, Jaber BL, Liu KD, Shea JA, Faubel S; Acute Kidney Injury Advisory Group of the American Society of Nephrology : The daily burden of acute kidney injury: A survey of U.S. nephrologists on World Kidney Day. Am J Kidney Dis 64: 394–401, 2014 - PubMed
    1. Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J: Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 104: 343–348, 1998 - PubMed
    1. Hsu CY, Chertow GM, McCulloch CE, Fan D, Ordoñez JD, Go AS: Nonrecovery of kidney function and death after acute on chronic renal failure. Clin J Am Soc Nephrol 4: 891–898, 2009 - PMC - PubMed